Literature DB >> 16858570

Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio.

Livia Tossici-Bolt1, Sandra M A Hoffmann, Paul M Kemp, Rajnikant L Mehta, John S Fleming.   

Abstract

PURPOSE: A technique is described for accurate quantification of the specific binding ratio (SBR) in [(123)I]FP-CIT SPECT brain images.
METHODS: Using a region of interest (ROI) approach, the SBR is derived from a measure of total striatal counts that takes into account the partial volume effect. Operator intervention is limited to the placement of the striatal ROIs, a task facilitated by the use of geometrical template regions. The definition of the image for the analysis is automated and includes transaxial slices within a "slab" approximately 44 mm thick centred on the highest striatal signal. The reference region is automatically defined from the non-specific uptake in the whole brain enclosed in the slab, with exclusion of the striatal region. A retrospective study consisting of 25 normal and 30 abnormal scans-classified by the clinical diagnosis reached with the scan support-was carried out to assess intra- and inter-operator variability of the technique and its clinical usefulness. Three operators repeated the quantification twice and the variability was measured by the coefficient of variation (COV).
RESULTS: The COVs for intra- and inter-operator variability were 3% and 4% respectively. A cutoff approximately 4.5 was identified that separated normal and abnormal groups with a sensitivity, specificity and diagnostic concordance of 97%, 92% and 95% respectively.
CONCLUSION: The proposed technique provides a reproducible and sensitive index. It is hoped that its independence from the partial volume effect will improve consistency in quantitative measurements between centres with different imaging devices and analysis software.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858570     DOI: 10.1007/s00259-006-0155-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  34 in total

1.  Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography.

Authors:  P D Acton; P T Meyer; P D Mozley; K Plössl; H F Kung
Journal:  Eur J Nucl Med       Date:  2000-11

2.  Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

Authors:  T S Benamer; J Patterson; D G Grosset; J Booij; K de Bruin; E van Royen; J D Speelman; M H Horstink; H J Sips; R A Dierckx; J Versijpt; D Decoo; C Van Der Linden; D M Hadley; M Doder; A J Lees; D C Costa; S Gacinovic; W H Oertel; O Pogarell; H Hoeffken; K Joseph; K Tatsch; J Schwarz; V Ries
Journal:  Mov Disord       Date:  2000-05       Impact factor: 10.338

3.  Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction.

Authors:  Albert Cot; Carles Falcón; Cristina Crespo; Josep Sempau; Deborah Pareto; Santiago Bullich; Francisco Lomeña; Francisco Calviño; Javier Pavía; Domènec Ros
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

4.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Authors:  J Booij; G Tissingh; G J Boer; J D Speelman; J C Stoof; A G Janssen; E C Wolters; E A van Royen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

5.  Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.

Authors:  J Booij; G Tissingh; A Winogrodzka; G J Boer; J C Stoof; E C Wolters; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-01

6.  Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

Authors:  J Booij; J B Habraken; P Bergmans; G Tissingh; A Winogrodzka; E C Wolters; A G Janssen; J C Stoof; E A van Royen
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

7.  Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.

Authors:  G Ransmayr; K Seppi; E Donnemiller; E Luginger; J Marksteiner; G Riccabona; W Poewe; G K Wenning
Journal:  Eur J Nucl Med       Date:  2001-10

8.  Effects of scatter and attenuation correction on quantitative analysis of beta-CIT brain SPET.

Authors:  J Hashimoto; T Sasaki; K Ogawa; A Kubo; N Motomura; T Ichihara; T Amano; Y Fukuuchi
Journal:  Nucl Med Commun       Date:  1999-02       Impact factor: 1.690

9.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.

Authors:  Z Walker; D C Costa; R W H Walker; K Shaw; S Gacinovic; T Stevens; G Livingston; P Ince; I G McKeith; C L E Katona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

10.  Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Authors:  J P Seibyl; K Marek; K Sheff; S Zoghbi; R M Baldwin; D S Charney; C H van Dyck; R B Innis
Journal:  J Nucl Med       Date:  1998-09       Impact factor: 10.057

View more
  71 in total

Review 1.  SPECT imaging evaluation in movement disorders: far beyond visual assessment.

Authors:  Kosmas Badiavas; Elisavet Molyvda; Ioannis Iakovou; Magdalini Tsolaki; Kyriakos Psarrakos; Nikolaos Karatzas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-02       Impact factor: 9.236

2.  Clinical profiles of late-onset psychiatric patients exhibiting incidental REM sleep without atonia.

Authors:  Hiroshige Fujishiro; Masato Okuda; Kunihiro Iwamoto; Seiko Miyata; Youta Torii; Shuji Iritani; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2019-06-22       Impact factor: 3.575

3.  Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database.

Authors:  Livia Tossici-Bolt; John C Dickson; Terez Sera; Robin de Nijs; Maria Claudia Bagnara; Catherine Jonsson; Egon Scheepers; Felicia Zito; Anita Seese; Pierre Malick Koulibaly; Ozlem L Kapucu; Michel Koole; Maria Raith; Jean George; Markus Nowak Lonsdale; Wolfgang Münzing; Klaus Tatsch; Andrea Varrone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236

4.  Corticobasal Syndrome in a Patient with Anti-IgLON5 Antibodies.

Authors:  Kimiharu Fuseya; Akio Kimura; Nobuaki Yoshikura; Megumi Yamada; Yuichi Hayashi; Takayoshi Shimohata
Journal:  Mov Disord Clin Pract       Date:  2020-05-05

5.  Impact of quantitative index derived from 123I-FP-CIT-SPECT on reconstruction with correction methods evaluated using a 3D-striatum digital brain phantom.

Authors:  Akihiro Furuta; Hideo Onishi; Noriyasu Yamaki; Nobuhiro Yada; Hizuru Amijima
Journal:  Radiol Phys Technol       Date:  2018-07-16

6.  Comment on Mertens et al.: Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.

Authors:  John S Fleming; Livia Tossici-Bolt; Matthew Guy; Paul Kemp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

7.  Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's Disease.

Authors:  Eugene Jeong; Sun Young Oh; Kisoo Pahk; Chan-Nyoung Lee; Kun-Woo Park; Jae Sung Lee; Gi Jeong Cheon; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2013-03-26

8.  Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [123I]FP-CIT SPECT images.

Authors:  Francisco P M Oliveira; Diogo Borges Faria; Durval C Costa; Miguel Castelo-Branco; João Manuel R S Tavares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-23       Impact factor: 9.236

9.  Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.

Authors:  Estelle Dellapina; Jean Pellaprat; Djilali Adel; Jerome Llido; Estelle Harroch; Jean Baptiste Martini; Aurélie Kas; Anne Sophie Salabert; Fabienne Ory-Magne; Pierre Payoux; Christine Brefel-Courbon
Journal:  J Neural Transm (Vienna)       Date:  2019-01-31       Impact factor: 3.575

10.  Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.

Authors:  Sule Tinaz; Christopher Chow; Phillip H Kuo; Elizabeth A Krupinski; Hal Blumenfeld; Elan D Louis; George Zubal
Journal:  Clin Nucl Med       Date:  2018-01       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.